EVOK
Closed
Evoke Pharma Inc
2.66
+0.06 (+2.31%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.6
Day's Range: 2.6 - 2.66
Send
sign up or login to leave a comment!
When Written:
1.9
Evoke Pharma Inc. is a biopharmaceutical company that focuses on the development of drugs for the treatment of gastrointestinal disorders and diseases. The company is headquartered in Solana Beach, California, and was founded in 2007.
Evoke Pharma's lead product candidate is Gimoti, a nasal spray formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult women. The company received FDA approval for Gimoti in June 2020 and launched the product in the United States in early 2021.
Evoke Pharma also has a pipeline of other product candidates in development for the treatment of gastrointestinal disorders, including EVK-001, a novel formulation of metoclopramide for the treatment of postoperative ileus and gastroparesis in adults.
The company has partnerships with several pharmaceutical companies, including Cato Research, a contract research organization, and Rondaxe, a pharmaceutical consulting firm. Evoke Pharma is publicly traded on the NASDAQ under the ticker symbol EVOK.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Evoke Pharma's lead product candidate is Gimoti, a nasal spray formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult women. The company received FDA approval for Gimoti in June 2020 and launched the product in the United States in early 2021.
Evoke Pharma also has a pipeline of other product candidates in development for the treatment of gastrointestinal disorders, including EVK-001, a novel formulation of metoclopramide for the treatment of postoperative ileus and gastroparesis in adults.
The company has partnerships with several pharmaceutical companies, including Cato Research, a contract research organization, and Rondaxe, a pharmaceutical consulting firm. Evoke Pharma is publicly traded on the NASDAQ under the ticker symbol EVOK.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!